Physician profile
Robert A Rauh
NPI 1437103256
$5,592.93
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,753 · 2020: $846 · 2021: $1,082 · 2022: $1,140 · 2023: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,718.77 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $1,185.60 | 2019-2023 | Xarelto |
| Pfizer INC. | $406.47 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $329.89 | 2019-2023 | Jardiance |
| Amgen INC. | $293.15 | 2019-2023 | Repatha |
| Novo Nordisk INC | $257.21 | 2021-2023 | Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $217.83 | 2019-2023 | Camzyos, Eliquis |
| Medtronic, INC. | $210.99 | 2021 | |
| Abiomed | $162.74 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $154.59 | 2020-2023 | Lifevest |
| Cardiovascular Systems INC. | $140.08 | 2019 | |
| Shockwave Medical, INC | $107.94 | 2021 | |
| Philips North America LLC | $95.86 | 2023 | |
| Kestra Medical Technology Services, INC. | $61.35 | 2022-2023 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $60.54 | 2019-2023 | Farxiga |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $51.64 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $42.03 | 2022-2023 | Verquvo |
| Boston Scientific Corporation | $29.48 | 2023 | Watchman Access System |
| Angiodynamics, INC. | $24.48 | 2021 | |
| Chiesi USA, INC. | $15.81 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.44 | 2021 | |
| Bard Peripheral Vascular, INC. | $13.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rauh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.